Julie R. Korenberg
No Rating Available
(Learn About Our Rating System)

Julie R. Korenberg, MD, PhD

Languages spoken: English, French, German, Spanish

Clinical Locations

Eccles Primary Children's Outpatient Services

Salt Lake City
801-213-3599

  • Dr. Korenberg, PhD, MD, received her PhD in Genetics followed by her post-doctoral fellowship in electron microscopy of human chromosomes (University of Wisconsin) and then her medical degree from the University of Miami School of Medicine Ph.D. - M.D. Program. She went on to complete her Pediatric residency at Children's Hospital Medical Center (CHMC) and Harvard University Medical School (HMS). Dr. Korenberg’s Fellowship as a Cystic Fibrosis Fellow (Clinical Pulmonology and Molecular Biology) was completed at HMS, Ina Sue Perlmutter Cystic Fibrosis Research Center and CHMC in Boston, MA. During this time, she also served as a physician in Emergency Medicine at a major trauma center. Her fellowship and boards in Medical Genetics followed at the University of California, San Francisco’s Moffitt Hospital. At the heart of Dr. Korenberg’s clinical and research lies her understanding of lifespan genetic defects, particularly those involving brain, nervous system and heart. As faculty in the Department of Pediatrics and Human Genetics at the University of California at Los Angeles, CSHS, she rose rapidly with multiple accelerations from Assistant Professor to Professor VIII and was bestowed with numerous honors for her pioneering work in Pediatrics, Medical Genetics, Human Genome, Molecular Genetic diagnosis for genetic syndromes and cancers, mouse models of human disease, and as a founder and founding member of the Department of Human Genetics, UCLA and at Cedars-Sinai Health System (CSHS). Dr. Korenberg also established the Neurofibromatosis Clinic and Programs for Down Syndrome and Williams Syndrome at CSHS. An international leader in neurodevelopmental disorders, DS “Protocols to establish genotype/phenotype correlations in Down syndrome,” the classic standard for diagnosis of Down Syndrome through the present work on clinical and fundamental work on genetic wiring of brain functions. National advisory boards in Clinical and Research, NIH service, study sections for NICHD, NIMH, Mental Retardation, National Institute of Child Health and Human Development (NICHD), Down syndrome Therapeutic Consortium, Williams syndrome diagnosis, treatment, genes for behavior. Specialties include lifespan work on Down syndrome, Williams syndrome, chromosomal abnormalities and more recently disorders of social behavior including autism and other psychiatric genetic conditions. Dr. Korenberg is certified by the American Boards of Pediatrics, Medical Genetics and Molecular Genetics and specializes in diagnosis and treatment of individuals with rare forms of conditions in these specialities, using a wholistic approach.

    Dr. Korenberg currently is USTAR Professor of Pediatrics, Director of the USTAR Cluster, Circuits of the Brain, Director of the Center for Integrated Neuroscience and Human Behavior and founder and director of the new Down Syndrome Therapeutic Consortium (DSTC) and of the emerging Williams Syndrome Program at the University of Utah. Dr. Korenberg is Faculty member in the Neuroscience Interdepartmental Graduate Program at the University of Utah. She holds numerous patents and leads the the National Institute of Child Health and Human Development (NICHD)-funded DSTC, has been awarded continuous funding for more than 25 years by institutions including the Department of Energy, the Alzheimer’s Foundation, the American Heart Association, the McDonnell Foundation and the State of Utah.

    Specialties

    Board Certification

    American Board of Medical Genetics (Clinical Genetics)
    American Board of Medical Genetics (Clinical Molecular Genetics)
    American Board of Pediatrics (Pediatrics)

  • Dr. Korenberg, PhD, MD, received her PhD in Genetics followed by her post-doctoral fellowship in electron microscopy of human chromosomes (University of Wisconsin) and then her medical degree from the University of Miami School of Medicine Ph.D. - M.D. Program. She went on to complete her Pediatric residency at Children's Hospital Medical Center (CHMC) and Harvard University Medical School (HMS). Dr. Korenberg’s Fellowship as a Cystic Fibrosis Fellow (Clinical Pulmonology and Molecular Biology) was completed at HMS, Ina Sue Perlmutter Cystic Fibrosis Research Center and CHMC in Boston, MA. During this time, she also served as a physician in Emergency Medicine at a major trauma center. Her fellowship and boards in Medical Genetics followed at the University of California, San Francisco’s Moffitt Hospital. At the heart of Dr. Korenberg’s clinical and research lies her understanding of lifespan genetic defects, particularly those involving brain, nervous system and heart. As faculty in the Department of Pediatrics and Human Genetics at the University of California at Los Angeles, CSHS, she rose rapidly with multiple accelerations from Assistant Professor to Professor VIII and was bestowed with numerous honors for her pioneering work in Pediatrics, Medical Genetics, Human Genome, Molecular Genetic diagnosis for genetic syndromes and cancers, mouse models of human disease, and as a founder and founding member of the Department of Human Genetics, UCLA and at Cedars-Sinai Health System (CSHS). Dr. Korenberg also established the Neurofibromatosis Clinic and Programs for Down Syndrome and Williams Syndrome at CSHS. An international leader in neurodevelopmental disorders, DS “Protocols to establish genotype/phenotype correlations in Down syndrome,” the classic standard for diagnosis of Down Syndrome through the present work on clinical and fundamental work on genetic wiring of brain functions. National advisory boards in Clinical and Research, NIH service, study sections for NICHD, NIMH, Mental Retardation, National Institute of Child Health and Human Development (NICHD), Down syndrome Therapeutic Consortium, Williams syndrome diagnosis, treatment, genes for behavior. Specialties include lifespan work on Down syndrome, Williams syndrome, chromosomal abnormalities and more recently disorders of social behavior including autism and other psychiatric genetic conditions. Dr. Korenberg is certified by the American Boards of Pediatrics, Medical Genetics and Molecular Genetics and specializes in diagnosis and treatment of individuals with rare forms of conditions in these specialities, using a wholistic approach.

    Dr. Korenberg currently is USTAR Professor of Pediatrics, Director of the USTAR Cluster, Circuits of the Brain, Director of the Center for Integrated Neuroscience and Human Behavior and founder and director of the new Down Syndrome Therapeutic Consortium (DSTC) and of the emerging Williams Syndrome Program at the University of Utah. Dr. Korenberg is Faculty member in the Neuroscience Interdepartmental Graduate Program at the University of Utah. She holds numerous patents and leads the the National Institute of Child Health and Human Development (NICHD)-funded DSTC, has been awarded continuous funding for more than 25 years by institutions including the Department of Energy, the Alzheimer’s Foundation, the American Heart Association, the McDonnell Foundation and the State of Utah.

    Board Certification and Academic Information

    Academic Departments Pediatrics -Primary
    Neurology -Adjunct
    Academic Divisions Medical Genetics
    Board Certification
    American Board of Medical Genetics (Clinical Genetics)
    American Board of Medical Genetics (Clinical Molecular Genetics)
    American Board of Pediatrics (Pediatrics)

    Education history

    Postdoctoral Fellowship Medical Genetics – Pediatrics - University of California - San Francisco Postdoctoral Fellow
    Cystic Fibrosis Fellow (Molecular Biology) - Harvard Medical School, Ina Sue Perlmutter Cystic Fibrosis Research Center Fellow
    Residency Pediatrics - Children's Hospital Medical Center, Harvard University Resident
    Pediatrics - Children's Hospital Medical Center, Harvard University Intern
    Professional Medical Ph.D. - M.D. Program - University of Miami School of Medicine M.D., Ph.D.
    Asst. Scientist, Departments of Zoology and Genetics - University of Wisconsin Postdoctoral Training
    Other Training Embryology Course and Research - Woods Hole Marine Biological Laboratory
    Medical Genetics - University of Wisconsin Ph.D.
    Graduate Training Medical Genetics - University of Wisconsin M.S.
    Genetics and Humanities - McGill University B.Sc.

    Selected Publications

    Journal Article

    1. Dai L, Weiss RB, Dunn DM, Ramirez A, Paul S, Korenberg JR (2020). Core transcriptional networks in Williams syndrome: IGF1-PI3K-AKT-mTOR, MAPK and actin signaling at the synapse echo autism. Hum Mol Genet, 30(6), 411-429. (Read full article)
    2. Chen XN, Korenberg JR (2002). BAC resource for molecular cytogenetics. Methods Mol Biol, 204, 391-403. (Read full article)
    3. Weier H, Munn S, Lersch RA, Hsieh H, Smida J, Chen X, Korenberg JR, Pedersen RA, Fung J (2001). Towards a full karyotype screening of interphase cells: 'FISH and chip' technology. Mol Cell Endocrinol, 183 Suppl 1, S41-5. (Read full article)
    4. Ianakiev P, Kilpatrick MW, Dealy C, Kosher R, Korenberg JR, Chen XN, Tsipouras P (1999). A novel human gene encoding an F-box/WD40 containing protein maps in the SHFM3 critical region on 10q24. Biochem Biophys Res Commun, 261(1), 64-70. (Read full article)
    5. Korenberg JR, Chen XN, Devon KL, Noya D, Oster-Granite ML, Birren BW (1999). Mouse molecular cytogenetic resource: 157 BACs link the chromosomal and genetic maps. Genome Res, 9(5), 514-23. (Read full article)
    6. Zhang X, Yang H, Corydon MJ, Zhang X, Pedersen S, Korenberg JR, Chen XN, Laporte J, Gregersen N, Niebuhr E, Liu G, Bolund L (1999). Localization of a human nucleoporin 155 gene (NUP155) to the 5p13 region and cloning of its cDNA. Genomics, 57(1), 144-51. (Read full article)
    7. Haldi ML, Strickland C, Lim P, VanBerkel V, Chen X, Noya D, Korenberg JR, Husain Z, Miller J, Lander ES (1996). A comprehensive large-insert yeast artificial chromosome library for physical mapping of the mouse genome. Mamm Genome, 7(10), 767-9. (Read full article)
    8. Korenberg JR, Chen XN, Tran H, Argraves WS (1995). Localization of the human gene for fibulin-1 (FBLN1) to chromosome band 22q13.3. Cytogenet Cell Genet, 68(3-4), 192-3. (Read full article)
    9. Malo MS, Srivastava K, Andresen JM, Chen XN, Korenberg JR, Ingram VM (1994). Targeted gene walking by low stringency polymerase chain reaction: assignment of a putative human brain sodium channel gene (SCN3A) to chromosome 2q24-31. Proc Natl Acad Sci U S A, 91(8), 2975-9. (Read full article)
    10. Wilson L, Curtis A, Korenberg JR, Schipper RD, Allan L, Chenevix-Trench G, Stephenson A, Goodship J, Burn J (1993). A large, dominant pedigree of atrioventricular septal defect (AVSD): exclusion from the Down syndrome critical region on chromosome 21. Am J Hum Genet, 53(6), 1262-8. (Read full article)
    11. Sainz J, Rasmussen M, Nechiporuk A, Vissing H, Cheng X, Korenberg JR, Pulst SM (1993). Dinucleotide repeat polymorphism at the D22S351 locus. Hum Mol Genet, 2(10), 1749. (Read full article)

    Patent

    1. Korenberg JR, Chen X (2006). Isolated SH3 genes associates with myeloproliferative disorders and leukemia and uses thereof. U.S. Patent No. 7,070,954. Washington, D.C.:U.S. Patent and Trademark Office.
    2. Korenberg JR, Chen (2006). “Isolated SH3 genes associates with myeloproliferative disorders and leukemia and uses thereof.”. U.S. Patent No. 7,070,954 B1. Washington, D.C.:U.S. Patent and Trademark Office.
    3. Korenberg JR, et al. (2000). "Chromosome 21 Gene Marker, Compositions & Methods Using Same". U.S. Patent No. 6,166,180. Washington, D.C.:U.S. Patent and Trademark Office.
    4. Korenberg JR (2000). "Congenital Heart Disease: Proteins and Products Related Hereto". U.S. Patent No. 6,040,429. Washington, D.C.:U.S. Patent and Trademark Office.